Author:
Gatti Milo,De Ponti Fabrizio
Publisher
Springer International Publishing
Reference71 articles.
1. Hines LE, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother. 2011;9(6):364–77.
2. Tannenbaum C, Sheehan NL. Understanding and preventing drug-drug and drug-gene interactions. Expert Rev Clin Pharmacol. 2014;7(4):533–44.
3. Thomsen LA, Winterstein AG, Søndergaard B, Haugbølle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother. 2007;41(9):1411–26.
4. Shapiro LE, Shear NH. Drug interactions: proteins, pumps, and P-450 s. J Am Acad Dermatol. 2002;47(4):467–84. quiz 485-8
5. US FDA. Guidance for Industry: drug metabolism/drug interactions in the drug development process: studies in vitro, 1997. Available from: www.fda.gov/cder/guidance/clin3.pdf